| Medical and Health Sciences | Lifetime | 427 | US 230 | 99.98 |
| Pulmonary and Respiratory Medicine | Lifetime | 16 | US 13 | 99.98 |
| Oncology | Lifetime | 341 | US 194 | 99.43 |
| Epidemiology | Lifetime | 612 | US 316 | 99.24 |
| Rheumatology | Lifetime | 780 | US 358 | 96.00 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 109 | US 37 | 99.29 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 2 | US 2 | 99.97 |
| Lung Cancer Treatments and Mutations | Lifetime | 7 | US 5 | 99.96 |
| Lung Cancer Research Studies | Lifetime | 6 | US 4 | 99.95 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 8 | US 6 | 99.89 |
| Medical Imaging and Pathology Studies | Lifetime | 7 | US 4 | 99.92 |
| Neuroendocrine Tumor Research Advances | Lifetime | 12 | US 7 | 99.85 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 67 | US 29 | 99.61 |
| Occupational and environmental lung diseases | Lifetime | 39 | US 18 | 99.29 |
| Eosinophilic Disorders and Syndromes | Lifetime | 64 | US 35 | 99.29 |
| Pleural and Pulmonary Diseases | Lifetime | 65 | US 31 | 99.18 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 36 | US 21 | 99.25 |
| Neuroblastoma Research and Treatments | Lifetime | 117 | US 63 | 99.08 |
| Soft tissue tumor case studies | Lifetime | 81 | US 48 | 98.75 |
| Cancer Genomics and Diagnostics | Lifetime | 621 | US 343 | 98.85 |
| Mast cells and histamine | Lifetime | 151 | US 67 | 97.87 |
| Tuberous Sclerosis Complex Research | Lifetime | 44 | US 30 | 97.53 |
| Metastasis and carcinoma case studies | Lifetime | 307 | US 43 | 97.55 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 291 | US 147 | 98.08 |
| Vasculitis and related conditions | Lifetime | 215 | US 63 | 97.70 |
| Cardiac tumors and thrombi | Lifetime | 436 | US 212 | 96.10 |
| Histiocytic Disorders and Treatments | Lifetime | 162 | US 95 | 95.84 |
| Myasthenia Gravis and Thymoma | Lifetime | 565 | US 189 | 94.04 |
| Tumors and Oncological Cases | Lifetime | 819 | US 412 | 93.23 |
| Gestational Trophoblastic Disease Studies | Lifetime | 342 | US 147 | 90.16 |
| Occupational exposure and asthma | Lifetime | 634 | US 187 | 91.71 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 691 | US 164 | 83.93 |
| Actinomycetales infections and treatment | Lifetime | 827 | US 200 | 71.94 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 89 | US 28 | 98.86 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 184 | US 71 | 98.78 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 151 | US 48 | 97.16 |
| Lung Cancer Research Studies | 2021-2025 | 590 | US 186 | 93.41 |
| Medical Imaging and Pathology Studies | 2021-2025 | 199 | US 68 | 89.43 |
| Occupational and environmental lung diseases | 2021-2025 | 146 | US 44 | 91.04 |
| Pleural and Pulmonary Diseases | 2021-2025 | 421 | US 95 | 82.86 |
| Occupational exposure and asthma | 2021-2025 | 657 | US 107 | 56.56 |
